Difference between revisions of "Alexander Denoon"
m |
|||
| Line 1: | Line 1: | ||
[[Alexander Denoon]] is a lawyer and owner of the London-based law practice [[Lawford Davies Denoon]].<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref> | [[Alexander Denoon]] is a lawyer and owner of the London-based law practice [[Lawford Davies Denoon]].<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref> | ||
| + | |||
| + | ==Background== | ||
The [[Lawford Davies Denoon]] website describes his role as follows: | The [[Lawford Davies Denoon]] website describes his role as follows: | ||
| Line 9: | Line 11: | ||
A ZoomInfo page of 2003 describes his duties at Biotech Australia: | A ZoomInfo page of 2003 describes his duties at Biotech Australia: | ||
| − | :While at Biotech Australia, his responsibilities included maintaining, managing and licensing the intellectual property of the entire portfolio that incorporated 20 different technologies covering human and animal health.Also, Denoon implemented the share and option plans for Biotech Australia, and the parent company Human Therapeutics Limited. While at Biotech Australia, Denoon conducted the initial public offering of the majority-owned subsidiary, Pi2 Limited. Associated with the float, Denoon established a corporate compliance program to reflect the greater level of reporting, disclosure and compliance generally associated with a public company.<ref>ZoomInfo (2012), [http://www.zoominfo.com/#!search/profile/person?personId=255463011&targetid=profile Alexander Denoon], acc 27 Nov 2012</ref> | + | :While at Biotech Australia, his responsibilities included maintaining, managing and licensing the intellectual property of the entire portfolio that incorporated 20 different technologies covering human and animal health. Also, Denoon implemented the share and option plans for Biotech Australia, and the parent company Human Therapeutics Limited. While at Biotech Australia, Denoon conducted the initial public offering of the majority-owned subsidiary, Pi2 Limited. Associated with the float, Denoon established a corporate compliance program to reflect the greater level of reporting, disclosure and compliance generally associated with a public company.<ref>ZoomInfo (2012), [http://www.zoominfo.com/#!search/profile/person?personId=255463011&targetid=profile Alexander Denoon], acc 27 Nov 2012</ref> |
| − | == | + | ==Biography== |
From his LinkedIn page as at November 2012:<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref> | From his LinkedIn page as at November 2012:<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref> | ||
Revision as of 00:19, 28 November 2012
Alexander Denoon is a lawyer and owner of the London-based law practice Lawford Davies Denoon.[1]
Background
The Lawford Davies Denoon website describes his role as follows:
- Alex advises clients in relation to the development of strategies for the protection, defence and commercialisation of intellectual property. This involves the development of strategies and the drafting of a wide array of commercial agreements from licences to joint ventures. Alex also advises in relation to the regulation of pharmaceuticals, medical devices and advanced therapy medicinal products.[2][3]
He is a director and a trustee of the Science Media Centre.[4][5]
Denoon has a BSc in human genetics and from 1998-2001 was general counsel and company secretary of Biotech Australia.[6][7]
A ZoomInfo page of 2003 describes his duties at Biotech Australia:
- While at Biotech Australia, his responsibilities included maintaining, managing and licensing the intellectual property of the entire portfolio that incorporated 20 different technologies covering human and animal health. Also, Denoon implemented the share and option plans for Biotech Australia, and the parent company Human Therapeutics Limited. While at Biotech Australia, Denoon conducted the initial public offering of the majority-owned subsidiary, Pi2 Limited. Associated with the float, Denoon established a corporate compliance program to reflect the greater level of reporting, disclosure and compliance generally associated with a public company.[8]
Biography
From his LinkedIn page as at November 2012:[9]
- Owner, Lawford Davies Denoon
- November 2009–Present (3 years 1 month)
- Senior Associate, Clifford Chance
- Partnership; 5001-10,000 employees; Law Practice industry
- May 2005–November 2009 (4 years 7 months)
- Special Adviser to the Board, Silverbrook Research
- Privately Held; 201-500 employees; Research industry
- 2003–2004 (1 year)
- General Counsel and Company Secretary, Redfern Broadband Networks
- 2001–2003 (2 years)
- General Counsel and Company Secretary, Biotech Australia
- 1998–2001 (3 years)
- Solicitor, Freehills
- Partnership; 1001-5000 employees; Law Practice industry
- 1995–1998 (3 years)
- Education
- University of New South Wales
- BSc, Human Genetics
- 1988–1994
- University of New South Wales
- LLB
- 1988–1994
Affiliations
He is a director and trustee of the Science Media Centre.[10][11]
According to his LinkedIn page, his "groups and associations" include groups associated with stem cell research, gene therapy and intellectual property (patents): Cell Therapy Industry group, CellFate, ELSI Subgroup, and Intellectual Property Professionals.[12]
Contact
- Address:
- ...
- ...
- ...
- ...
- Phone:
- ...
- Email:
- ...
- Website:
- ...
Resources
Notes
- ↑ LinkedIn, Alexander Denoon, acc 26 Nov 2012
- ↑ Lawford Davies Denoon (2012) Alexander Denoon, acc 26 Nov 2012
- ↑ LinkedIn, Alexander Denoon, acc 3 Oct 2012
- ↑ Companies House (2012) Current Appointments Report for: Science Media Centre, created 23/11/2012, obtained from Companies House 23 Nov 2012
- ↑ Charity Commission (2012), Science Media Centre Trustees' Report and Accounts for period ended 31 March 2012, acc 3 Oct 2012
- ↑ Lawford Davies Denoon (2012) Alexander Denoon, acc 3 Oct 2012
- ↑ LinkedIn, Alexander Denoon, acc 3 Oct 2012
- ↑ ZoomInfo (2012), Alexander Denoon, acc 27 Nov 2012
- ↑ LinkedIn, Alexander Denoon, acc 26 Nov 2012
- ↑ Companies House (2012) Current Appointments Report for: Science Media Centre, created 23/11/2012, obtained from Companies House 23 Nov 2012
- ↑ Charity Commission (2012), Science Media Centre Trustees' Report and Accounts for period ended 31 March 2012, acc 3 Oct 2012
- ↑ LinkedIn, Alexander Denoon, acc 26 Nov 2012
